Deepak Kanojia
About Deepak Kanojia
Deepak Kanojia is a Senior Scientist at Mythic Therapeutics, Inc., specializing in rational combination therapeutic strategies for cancer treatment. He has extensive academic and research experience, including roles at various prestigious institutions and contributions to notable conferences and publications in the field of biochemistry and oncology.
Work at Mythic Therapeutics
Deepak Kanojia serves as a Senior Scientist at Mythic Therapeutics, Inc. since 2021. In this role, he focuses on developing rational combination therapeutic strategies specifically for cancer treatment. His work involves managing a team of junior postdoctoral researchers and professional technicians, facilitating research efforts aimed at advancing cancer therapies.
Education and Expertise
Deepak Kanojia has an extensive educational background in Biochemistry. He earned his M.Sc. from The Maharaja Sayajirao University of Baroda from 2000 to 2002. He further pursued a Ph.D. in Biochemistry at the University of Mumbai from 2005 to 2010. His expertise encompasses antibody-delivery methods aimed at cancer therapy, and he has a strong foundation in both basic science and clinical research.
Professional Experience
Before joining Mythic Therapeutics, Deepak Kanojia held various positions in esteemed institutions. He worked as a Research Associate at Northwestern University, Feinberg School of Medicine from 2016 to 2020, and as a Research Assistant Professor at Northwestern University from 2020 to 2021. His earlier roles include Postdoctoral Fellow at the University of South Carolina and Postdoctoral Scholar at the University of Chicago Medicine. He also has experience as a Quality Assurance Specialist at Lambda Therapeutic Research.
Editorial Role at Journal of Cellular and Molecular Medicine
Since 2021, Deepak Kanojia has been serving as an Associate Editor for the Journal of Cellular and Molecular Medicine. In this capacity, he contributes to the peer-review process and editorial decisions, ensuring the quality and integrity of published research in the field of cellular and molecular medicine.
Research Contributions and Presentations
Deepak Kanojia has actively participated in various conferences and has co-authored journal articles. He presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in October 2023 and at the American Association of Cancer Research (AACR) Annual Meeting in April 2023 and April 2024. His co-authored works include articles on bispecific antibodies and MYTX-011, showcasing his contributions to cancer research.